Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-992-2 | CAS number: 101-96-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
A skin sensitisation test was performed with 44PD testing different concentrations. The study was performed under GLP and scored Klimisch 2. The test substance was found to be skin sensitizing already at a induction/challenge concentration of 0.1%.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented study which meets basic scientific principles.
- Justification for type of information:
- Key study, GLP, Klimisch score 2
- Principles of method if other than guideline:
- According to G. Klecak: Identification of Contact Allergens (Predictive Tests in Animals) in: Advances in Modern Toxicology Vol. 4, - Dermatotoxicology and Pharmacology -, ed. F. N. Marzulli, H.I. Maibach, pp. 321 - 324 (1977)
- GLP compliance:
- yes
- Type of study:
- open epicutaneous test
- Justification for non-LLNA method:
- The test was performed in 1984, before LLNA was selected as the first-choice test and before OECD 429 was adopted.
- Species:
- guinea pig
- Strain:
- other: Pirbright White, Dunkin Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Lippische Versuchstierzucht, Hagemann GmbH & Co., KG, Exertal, Germany
- Weight at study initiation: mean 258 - 428 g (1. Experiment); mean 244 - 309 g (2. Experiment)
- Housing: 4 animals in Makrolon Type IV cages
- Diet: Ssniff GK 4 mm (Standard diet for rabbits and guinea pigs), ad libitum
- Water: tap water, ad libitum (2x times a week addition of 2 g ascorbic acid to 10 L water)
- Acclimation period: at least 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- epicutaneous, open
- Vehicle:
- other: ethanol
- Concentration / amount:
- 0.1, 0.3, 1 and 3% in ethanol
- Route:
- epicutaneous, open
- Vehicle:
- other: ethanol
- Concentration / amount:
- 0.1, 0.3, 1 and 3% in ethanol
- No. of animals per dose:
- 8
- Details on study design:
- RANGE FINDING TESTS: In a pre-test 0.025 mL/cm² of 10, 3, 1 and 0.3% test substance in ethanol and conc. ethanol were applied to the skin of guinea pigs (epicutaneous open). 1% was found to be the minimal irritating concentration and 0.3% as the maximal non-irritating concentration. Readings were conducted 24, 48 and 72 hours following application.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 20
- Exposure period: 24 h epicutaneous
- Test groups:
application of vehicle (conc. ethanol)
- Control group:
application of test substance in ethanol
- Site: right flank (for the 3% solution application site was changed from cranial to caudal due to severe irritation reactions cranial)
- Frequency of applications: daily on week days
- Duration: 26 days
- Concentrations: 0.005, 0.01 (Experiment II), 0.1, 0.3, 1, 3% (Experiment I)
B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge: 28 and 42
- Exposure period: 72 hours
- Test groups: epicutaneous challenge with 4 (experiment I), 2 (Experiment II) test substance concentrations (1. and 2. challenge)
- Control group: epicutaneous challenge with test substance (2. challenge all groups; 1. challenge one control group was challenged with ethanol)
- Site: left flank
- Concentrations: 0.005, 0.01, 0.1, 0.3, 1, 3%
- Evaluation (hr after challenge): 0.005, 0.01 (Experiment II), 0.1, 0.3, 1, 3% (Experiment I) - Positive control substance(s):
- no
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.1% induction, 0.3% challenge
- No. with + reactions:
- 8
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.1% induction, 0.3% challenge. No with. + reactions: 8.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.3% induction, 0.3% challenge
- No. with + reactions:
- 8
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.3% induction, 0.3% challenge. No with. + reactions: 8.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1% induction, 0.3% challenge
- No. with + reactions:
- 7
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1% induction, 0.3% challenge. No with. + reactions: 7.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3% induction, 0.3% challenge
- No. with + reactions:
- 7
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 3% induction, 0.3% challenge. No with. + reactions: 7.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.1% induction, 0.1% challenge
- No. with + reactions:
- 2
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.1% induction, 0.1% challenge. No with. + reactions: 2.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.3% induction, 0.1% challenge
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.3% induction, 0.1% challenge. No with. + reactions: 0.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1% induction, 0.1% challenge
- No. with + reactions:
- 1
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1% induction, 0.1% challenge. No with. + reactions: 1.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3% induction, 0.1% challenge
- No. with + reactions:
- 4
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 3% induction, 0.1% challenge. No with. + reactions: 4.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.005 or 0.01% induction, 0.005 or 0.01% challenge
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Clinical observations:
- no reactions were seen for both dose groups
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.005 or 0.01% induction, 0.005 or 0.01% challenge. No with. + reactions: 0.0. Total no. in groups: 8.0. Clinical observations: no reactions were seen for both dose groups.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.1% induction, 0.1% challenge
- No. with + reactions:
- 3
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.1% induction, 0.1% challenge. No with. + reactions: 3.0. Total no. in groups: 8.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.3% induction, 0.1% challenge
- No. with + reactions:
- 5
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.3% induction, 0.1% challenge. No with. + reactions: 5.0. Total no. in groups: 8.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1% induction, 0.1% challenge
- No. with + reactions:
- 5
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1% induction, 0.1% challenge. No with. + reactions: 5.0. Total no. in groups: 8.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3% induction, 0.1% challenge
- No. with + reactions:
- 5
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 3% induction, 0.1% challenge. No with. + reactions: 5.0. Total no. in groups: 8.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.005 or 0.01% induction, 0.005 or 0.01% challenge
- No. with + reactions:
- 0
- Total no. in group:
- 8
- Clinical observations:
- no reactions were seen for both dose groups
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.005 or 0.01% induction, 0.005 or 0.01% challenge. No with. + reactions: 0.0. Total no. in groups: 8.0. Clinical observations: no reactions were seen for both dose groups.
- Interpretation of results:
- sensitising
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- DSD: Xi, R43
CLP: Cat. 1, H317
Reference
Table 1. Results of Experiment I
|
Concentrations of |
||||||||
|
Induction |
Challenge |
Challenge |
||||||
|
|
3% |
1% |
0.3% |
0.1% |
3% |
1% |
0.3% |
0.1% |
Control 1 |
a |
8/8 |
4/8 |
0/8 |
0/8 |
8/8 |
8/8 |
4/8 |
0/8 |
Control 2 |
a |
0/8 a |
0/8 a |
0/8 a |
0/8 a |
8/8 |
7/8 |
0/8 |
0/8 |
Exp. 1 |
3% |
8/8 |
8/8 |
7/8 |
4/8 |
8/8 |
8/8 |
8/8 |
5/8 |
Exp. 2 |
1% |
8/8 |
8/8 |
7/8 |
1/8 |
8/8 |
8/8 |
8/8 |
5/8 |
Exp. 3 |
0.3% |
8/8 |
8/8 |
8/8 |
0/8 |
8/8 |
8/8 |
8/8 |
5/8 |
Exp. 4 |
0.1% |
8/8 |
8/8 |
8/8 |
2/8 |
8/8 |
8/8 |
8/8 |
3/8 |
a = Ethanol (vehicle control); x/y = no. of positive reactions/no. of application sites 48 hours after challenge
Control 2 was challenged using vehicle at first challenge
Table 2. Results of Experiment II
|
Concentrations of |
||||
|
Induction |
Challenge |
Challenge |
||
|
|
0.01% |
0.005% |
0.01% |
0.005% |
Control 1 |
a |
0/8 |
0/8 |
0/8 |
0/8 |
Control 2 |
a |
0/8 a |
0/8 a |
0/8 |
0/8 |
Exp. 1 |
0.01% |
0/8 |
0/8 |
0/8 |
0/8 |
Exp. 2 |
0.005% |
0/8 |
0/8 |
0/8 |
0/8 |
a = Ethanol (vehicle control); x/y = no. of positive reactions/no. of application sites 48 hours after challenge
Control 2 was challenged using vehicle at first challenge
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
A skin sensitisation test was performed with 44PD testing different concentrations. Clear sensitizing reactions could be identified using 0.1 and 0.3% concentrations for the first challenge. No control animal showed skin reactions but almost all test substance induced animals showed sensitizing effects. For the second challenge 4 control animals showed reactions when re-challenged with 0.3% whereas no control animal re-challenged with 0.1% showed skin reactions and therefore again sensitizing potential for all animals induced with test substance could be identified.
Induction and challenge/re-challenge with 0.005 or 0.01% did neither result in skin nor in sensitizing reactions.
Therefore, the test substance was found to be skin sensitizing already at a induction/challenge concentration of 0.1%.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the fact that the study performed with 44PD revealed that skin sensitization already occurs at a concentration of 0.1%, a classification of the substance as Skin Sensitising Cat. 1A is deemed required. The corresponding hazard statement is H317: May cause an allergic skin reaction. For the labelling the GHS07 pictogram (exclamation mark) and the signal word “Warning” are assigned to this category.
The classification according to Directive 67/548 (DSD) is “ May cause sensitisation by skin contact” with R43 as the corresponding risk phrase.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Damit Sie die Website optimal nutzen können, verwenden wir Cookies.